Zoetis Inc. (ZTS)

Zoetis Inc. (ZTS) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $83.78, down 0.72% on the day, which values the company at $34.04B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$83.78−0.72% today
Market value
$34.04B
P/E ratio
14.2×last 12 months
Forward P/E
13.1×
Dividend yield
2.48%
Funk Score
72/100
Against its own history
Well below its usual priceusual price $186.06
200-week average
$150.9845% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Zoetis Inc. in more detail

ZTS trades at 14.2× its last twelve months' earnings, 13.1× next year's expected earnings, 3.6× sales. Measured against its own history, the price is 55% below what its usual multiples would imply ($186.06) — well below its usual price. It sits 45% below its 200-week average of $150.98.

Over the last five fiscal years Zoetis Inc. has compounded revenue 7.2% a year, earnings per share 12.0% a year, free cash flow 6.4% a year. Its Funk Score is 72 out of 100 (financial strength 6.8, profitability 9.3, growth 5.6, value 7.1, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Debt is growing faster than cash flow.

13 of the superinvestors tracked here hold ZTS, including Tweedy, Browne team (3.7% of the portfolio), Sequoia Fund team (2.4% of the portfolio), Bill Smead (2.3% of the portfolio).

Superinvestors holding ZTS

13 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ZTS vs RMD (Zoetis Inc. vs ResMed)ZTS vs ILMN (Zoetis Inc. vs Illumina)ZTS vs GMAB (Zoetis Inc. vs Genmab)ZTS vs CNC (Zoetis Inc. vs Centene)ZTS vs MTD (Zoetis Inc. vs Mettler-Toledo International)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Zoetis Inc. (ZTS): questions and answers

What is ZTS's P/E ratio?

Zoetis Inc. trades at 14.2× its last twelve months' earnings and 13.1× next year's expected earnings. At its fiscal year-ends over the past 13 years the P/E ranged from 20.9× to 70.5×, with a median of 37.1×.

What is ZTS's PEG ratio?

Zoetis Inc.'s PEG ratio is 3.96 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Zoetis Inc.'s market cap?

Zoetis Inc. is valued at $34.04B at a share price of $83.78.

Is ZTS overvalued or undervalued?

Against its own history, ZTS is well below its usual price: the price is 55% below the $186.06 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ZTS above its 200-week moving average?

No. ZTS is 44.5% below its 200-week average of $150.98. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Zoetis Inc. growing?

Over the last five fiscal years Zoetis Inc.'s revenue grew 7.2% a year and its earnings per share 12.0% a year; over ten years revenue grew 7.1% a year.

Cite this page

Funkfolio, “Zoetis Inc. (ZTS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ZTS

Underlying data: Yahoo Finance; company filings with the SEC.